Marshall Wace North America L.P. - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 45 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q3 2021$223,000
-88.2%
5,819
-91.3%
0.00%
-87.5%
Q2 2021$1,885,000
-35.9%
66,761
-24.9%
0.01%
-33.3%
Q1 2021$2,940,000
-17.3%
88,947
-9.5%
0.01%
-25.0%
Q4 2020$3,553,000
+10.8%
98,276
+3.9%
0.02%
-23.8%
Q3 2020$3,206,00094,5800.02%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$618,113,61997.50%
venBio Partners LLC 1,035,396$57,050,32017.69%
Vivo Capital, LLC 2,606,247$143,60416.53%
Nan Fung Group Holdings Ltd 368,665$20,313,44214.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 264,500$14,560,7254.50%
NEUMEIER POMA INVESTMENT COUNSEL LLC 685,340$37,762,2343.51%
ASHFORD CAPITAL MANAGEMENT INC 356,638$19,650,7543.05%
TANG CAPITAL MANAGEMENT LLC 281,200$15,494,1202.25%
MPM BioImpact LLC 139,377$7,679,6731.99%
O'Neil Global Advisors, Inc. 7,335$4041.86%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders